Pluri (PLUR) Days Payable : 1,414.38 (As of Dec. 2024)

View and export this data going back to 1991. Start your Free Trial

What is Pluri Days Payable?

Pluri's average Accounts Payable for the three months ended in Dec. 2024 was $1.15 Mil. Pluri's Cost of Goods Sold for the three months ended in Dec. 2024 was $0.07 Mil. Hence, Pluri's Days Payable for the three months ended in Dec. 2024 was 1,414.38.

The historical rank and industry rank for Pluri's Days Payable or its related term are showing as below:

PLUR' s Days Payable Range Over the Past 10 Years
Min: 1968.08 Med: 110587.98 Max: 505707.5
Current: 1968.08

During the past 13 years, Pluri's highest Days Payable was 505707.50. The lowest was 1968.08. And the median was 110587.98.

PLUR's Days Payable is ranked better than
90.04% of 703 companies
in the Biotechnology industry
Industry Median: 122.89 vs PLUR: 1968.08

Pluri's Days Payable increased from Dec. 2023 (0.00) to Dec. 2024 (1,414.38). It may suggest that Pluri delayed paying its suppliers.

Pluri Days Payable Historical Data

The historical data trend for Pluri's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pluri Days Payable Chart

Pluri Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Days Payable

Get a 7-Day Free Trial

72,939.17

126,655.00

Pluri Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Days Payable	Get a 7-Day Free Trial															-	-	-	757.88	1,414.38

Competitive Comparison of Pluri's Days Payable

For the Biotechnology subindustry, Pluri's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pluri's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pluri's Days Payable distribution charts can be found below:

* The bar in red indicates where Pluri's Days Payable falls into.

Save Embed

;

Save Embed

;

Pluri Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Pluri's Days Payable for the fiscal year that ended in Jun. 2024 is calculated as

	Days Payable (A: Jun. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Jun. 2023 )	+	Accounts Payable (A: Jun. 2024 ))	/	count )	/	Cost of Goods Sold (A: Jun. 2024 )	*	Days in Period
=	( (1.812	+	0.964)	/	2 )	/	0.004	*	365
=	1.388					/	0.004	*	365
=	126,655.00

Pluri's Days Payable for the quarter that ended in Dec. 2024 is calculated as:

	Days Payable (Q: Dec. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Sep. 2024 )	+	Accounts Payable (Q: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2024 )	*	Days in Period
=	( (1.129	+	1.165)	/	2 )	/	0.074	*	365 / 4
=	1.147					/	0.074	*	365 / 4
=	1,414.38

Pluri Days Payable Related Terms

Thank you for viewing the detailed overview of Pluri's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Pluri Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pluri Inc (NAS:PLUR) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

PLUR:Israel

Address

MATAM Advanced Technology Park, Building No.5, Haifa, ISR, 3508409

Website

https://www.pluri-biotech.com

Pluri Inc is a biotechnology company, that creates cell-based products for commercial use and is pioneering a biotech revolution that promotes wellbeing and sustainability. The company's technology platform developed a three-dimensional, or 3D, technology platform for cell expansion with an industrial scale in-house Good Manufacturing Practice, or GMP, cell manufacturing facility. It uses its technology in the field of regenerative medicine, food tech and agricultural technology or agtech.

Executives

Lorne Kenneth Abony	director	MATAM PARK, BUILDING #5, HAIFA L3 3508409
Zami Aberman	officer: Chief Executive Officer	63 RABUTZKY STREET, RAANANA L3 43220
Varda Shalev	director	MATAM PARK, BUILDING #5, HAIFA L3 3508409
Pinhas Doron Birger	director	MATAM PARK, BUILDING #5, HAIFA L3 3508409
Clover Wolf Capital - Limited Partnership	10 percent owner	BOODENHIMER 24, TEL AVIV L3 6200838
Rami Avraham Levi	director	MATAM ADVANCED TECHNOLOGY PARK, BUILDING NO. 5, HAIFA L3 3508409
Maital Shemesh-rasmussen	director	MATAM ADVANCED TECHNOLOGY PARK, BUILDING NO. 5, HAIFA L3 3508409
Doron Shorrer	director	33 KOREH PLADORR ST, JERUSALEM L3 93393
Isaac Braun	director	9 ZEHARIA STREET, BENE BARAK L3 51540
Yaky Yanay	officer: Chief Financial Officer	ARGAMAN 14, SHIMSHIT L3 17906
Moria Kwiat	director	HAKFAR 11, KIRYAT ONO L3 55525
Israel Ben-yoram	director	24 BARKAN STREET, RISHON LEZION L3 00000
Chen Franco-yehuda	officer: Chief Financial Officer	MATAM ADVANCED TECHNOLOGY PARK, BUILDING NO. 5, HAIFA L3 31905
Mark Germain	director	WELLSFORD REAL PROPERTIES INC, 535 MADISON AVENUE, NEW YORK NY 10022
Erez Egozi	officer: Chief Financial Officer	MATAM PARK, BUILDING 05, HAIFA L3 31905